Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hemogenyx Pharmaceuticals Plc. (OP:HOPHF)

0.0031 UNCHANGED
Last Price Updated: 12:21 PM EDT, Aug 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0031
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0031
Today's Range 0.0031 - 0.0031
52wk Range 0.0031 - 0.0400
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces First Patient Safety
Via ACCESS Newswire

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
-92.3%
-92.3%

More News

Read More
Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Ultrafast CAR-T Manufacturing
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
Via ACCESS Newswire
Hemogenyx Pharmaceuticals PLC Announces CBR Macrophage Delivery Update
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Notice of Extraordinary General Meeting
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces IRB Approval for Phase I Clinical Trial
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Institutional Investment
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Strategic Investment from Prevail Partners, LLC
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces CDX Development Update
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Macrophage-Directed Therapies Summit Presentation
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Operations Update
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC - FLT3 Assay Ready for Phase I Trials at MD Anderson
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Presentation at CBD S&T Conference
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Result of Annual General Meeting
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Final Results
Via ACCESSWIRE
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
Via ACCESSWIRE
Hemogenyx Pharmaceuticals discusses successful £3.5M capital raise as it advances HEMO-CAR-T program
Via News Direct

Frequently Asked Questions

Is Hemogenyx Pharmaceuticals Plc. publicly traded?
Yes, Hemogenyx Pharmaceuticals Plc. is publicly traded.
What exchange does Hemogenyx Pharmaceuticals Plc. trade on?
Hemogenyx Pharmaceuticals Plc. trades on the OTC Traded
What is the ticker symbol for Hemogenyx Pharmaceuticals Plc.?
The ticker symbol for Hemogenyx Pharmaceuticals Plc. is HOPHF on the OTC Traded
What is the current price of Hemogenyx Pharmaceuticals Plc.?
The current price of Hemogenyx Pharmaceuticals Plc. is 0.0031
When was Hemogenyx Pharmaceuticals Plc. last traded?
The last trade of Hemogenyx Pharmaceuticals Plc. was at 08/05/24 12:21 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.